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Background: Cardiopulmonary bypass (CPB) is usually associated with inflammatory response that leads to various
degrees of organ dysfunction in multiple systems, including lung injury. Our previous study showed that
transforming growth factor beta1 (TGFβ1) was involved in CPB-induced lung injury. N-acetylcysteine (NAC) is an
antioxidant and is able to prevent CPB-induced pneumocyte apoptosis through scavenging radical. Therefore, we
investigated whether NAC may attenuate CPB-induced lung injury by inhibiting TGFβ1 expression.
Methods: Fifty-four 18 to 24-month-old mongrel dogs (15–16 kg) were randomly divided into control group, CPB
group and NAC group (n = 18). Six dogs in each group were killed prior to, as well as 30 and 60 minutes after the
operation (T0, T1 and T2). Lung injury was evaluated by hematoxylin and eosin (H&E) staining. Respiratory index (RI),
oxygenation index (OI), malondialdehyde (MDA) content and superoxide dismutase (SOD) activity in the lung were
determined at each time point. TGFβ1 expression was determined using real time RT-PCR and immunohistochemistry.
Results: A serious lung injury was observed after CPB in dogs. RI and MDA content were increased significantly after
CPB, whereas OI and SOD activity were decreased. H&E staining showed that NAC treatment obviously attenuated
CPB-induced lung injury. NAC treatment upregulated OI and SOD activity and downregulated RI and MDA content in
the lung tissues of dogs after CPB. Treatment with NAC significantly suppressed the TGFβ1 expression in the lung
tissues at both mRNA and protein levels.
Conclusion: Our results suggest that NAC is a potent agent against CPB-induced acute lung injury through inhibiting
TGFβ1 expression.
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Cardiopulmonary bypass (CPB), which is an essential
technique for cardiac surgery, usually induces acute lung
injury [1]. Lung injury clinically affects a small number of
patients who undergo CPB. It is part of the CPB-induced
organ dysfunction that may cause a collapsed lung and
may develop into acute respiratory distress syndrome
(ARDS) [1]. Therefore, CPB-induced acute lung injury is
one of the main reasons for death after cardiac surgery [2].
Transforming growth factor beta1 (TGFβ1), a cytokine
with complex functions, is able to regulate cell
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reproduction in any medium, provided the orin the inflammatory response and tissue repair [3-6]. It
has been reported that TGFβ1 participates in the
endotoxin-induced acute lung injury through TGFβ1-
Smad2 pathway [7]. TGFβ1 is abundantly expressed in the
bronchoalveolar lavage fluid of the patients with ARDS
during the early stage [8]. In our previous work, we also
found the expression of TGFβ1 was upregulated in
CPB-induced acute lung injury in dogs. It can directly
increase the permeability of pulmonary artery endothelial
cells and alveolar epithelial cells, resulting in the formation
of pulmonary edema, the releasing of proinflammatory
cytokines and thereby aggravating lung injury [9-11].
TGFβ1 also participates in the progression of lung fibrosis
following injury [12]. Furthermore, TGFβ1 may aggravate
the lung injury through increasing endothelial [13] and
epithelial permeability [14] and decreasing ion and fluid
transport [15,16]. In view of the important role of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of TGFβ1 may be a potential therapeutic strategy for
reducing CPB-induced acute lung injury.
N-acetylcysteine (NAC) is an antioxidant that could
scavenge oxygen free radicals with protective effects on
cells and microcirculation [17]. NAC is able to alleviate
lung reperfusion injury induced by deep hypothermic
circulatory arrest through scavenging oxygen free radicals
[18]. It can reduce the pulmonary vascular resistance
index and decrease the incidence of lung injury after
off-pump coronary artery bypass surgery [19]. Interestingly,
NAC can also prevent CPB-induced pneumocyte
apoptosis through scavenging radical [20]. However,
the relationship between NAC treatment and TGFβ1
expression in lung tissues has not been reported. In view
of the important role of TGFβ1 during the progression
of acute lung injury, the objective of this work was to
investigate whether NAC could exert a protective effect
on CPB-induced acute lung injury through inhibiting the
expression of TGFβ1.
Methods
Animals and experiment design
Fifty-four 18 to 24-month-old mongrel dogs (15 ~ 16 kg)
were purchased from the Experimental animal center
of Zhejiang University. These dogs were randomly
assigned into the control group, CPB group and NACFigure 1 HE staining of lung tissues. HE staining was performed to dete
each group were examined (×200).group (n = 18). Dogs were anesthetized with 2% sodium
pentobarbital (i.p., 30 mg · kg-1), placed on a constant-
temperature operating table and then endotracheal
intubation was carried out. The animal was placed on an
AH-II animal ventilator (Beijing science and Technology
Development Company, Beijing, China) in the volume
control mode. Initial ventilatory settings included: FIO2
1.0, delivered tidal volume measured at the endotracheal
tube 12 ml · kg-1. The respiratory rate (RR) was adjusted
according to the result of blood gas analysis to maintain
the PaCO2 between 35 and 40 mmHg. Mean arterial
pressure (MAP) and central venous pressure (CVP) were
monitored by an Intellivue MP50type multifunctional
monitor (Philips, Holland) through placing femoral
arterial and femoral venous catheters. Anesthesia was
maintained with a continuous infusion of fentanyl (100 μg ·
kg-1 · min-1). Intermittent boluses of vecuronium bromide
(0.1 mg · kg-1) was administered for neuromuscular
blockade. The lung injury after CPB was induced
according to the method reported by Williams et al. [21].
Briefly, after a median sternotomy, the pericardium was
incised. After administration of heparin (3 mg · kg-1),
cannulation was accomplished by placing an 8-French
infant arterial cannula in the ascending aorta and a single
22-French venous cannula in the right atrium. Each dog
was placed on conventional nonpulsatile CPB at a flow of
(125 ml · kg-1 · min-1). Five minutes later, each animal wasct the lung injury of dogs at three different time points. Six dogs in
Table 1 The scores of lung injury at T2 time point (n = 6)
Group Lung injury score
Control 0.5 (0–1)
CPB 10.5 (7–14) a
NAC 4 (2–5) b
Data are expressed as median (range). Compared with control group, a P < 0.05;
compared with CPB group, b P < 0.05.
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of 25°C. After cooling, the bypass flow was adjusted
to 35 ml · kg-1 · min-1 for 60 mins, which achieved a mean
arterial pressure of 35 ~45 mm Hg. During this period of
low-flow CPB, the ventilator was set to deliver a constant
positive airway pressure of 10 cm H2O with the FIO2
decreased to 0.21. After the 60-min period of low-flow
CPB, the ventilator settings were adjusted to FIO2 1.0,
delivered tidal volume of 12 ml · kg-1. After rewarming to
37 °C for 20 mins, the animals were removed from CPB.
Post CPB, adrenaline (1:1000, 0.1 ml · kg-1) and dopamine
(10 μg · kg-1 · min-1) were administered for 60 min by a
venous pump. Dogs in the control group underwent the
same operation except for CPB. The dogs in NAC group
were injected intravenously with NAC (Batch No.
2009081606, Sigma, USA) (150 mg · kg-1) through femoral
vein before CPB according to the method in reference
[22]. Then the dogs were continuously infused with NAC
(20 mg · kg-1 · h-1) during the CPB process until the end of
the experiment. The dogs in control group and CPB group
were injected with equivalent normal saline. Six dogs in
each group were sacrificed before CPB (T0), 30 min after
CPB (T1) and 60 min after CPB (T2) and 2 ml arterial
blood was obtained from each dog at each time point.
Pulmonary tissues were sampled for future determination.
The experiments were performed in accordance with the
Helsinki Declaration of 1975 and approved by the Ethics
Committee of Taizhou University Medical School. All the
animals used in the study received humane care.
Respiratory index (RI) and oxygenation index (OI)
were determined with the arterial blood using a
GEMpremier ™3000 Blood gas analyzer (Instrumentation
Laboratory, Ann Arbor, Michigan, USA).
Malondialdehyde (MDA) content and SOD activity of
lung were measured using the thiobarbituric sodium
method and xanthine oxidase method, respectively.Table 2 Effect of NAC on the levels of RI and OI
Group RI
T0 T1 T2
Control 0.72 ± 0.03 0.74 ± 0.33 0.75 ± 0
CPB 0.71 ± 0.04 4.71 ± 0.55 ab 5.10 ± 0.1
NAC 0.75 ± 0.04 0.79 ± 0.41 ac 1.07 ± 0.6
Blood samples were obtained from femoral artery at indicated time points and then
Compared with T0 time point, a P < 0.05; compared with control group, b P < 0.05; cBriefly, after the lung tissues were rinsed in pre-cool
saline to remove the blood, the lung tissues were
weighed and homogenized in 9 times the volume of
homogenate medium (saline) using a Soniprep150
ultrasonic disintegrator (MSE company, United States).
Then the homogenate was centrifuged at 3000 g for
12 min and supernatant was saved. The MDA content
and SOD activity were measured with commercial kits
from Nanjin Jiancheng Bioengineering Institute (Nanjing,
China) using BeckmanDU800 (Beckman company, the
United States of America) visible light analyzer.
Hematoxylin and Eosin Staining
Pulmonary tissues were fixed with 4% paraformaldehyde,
embedded in paraffin and stained with Hematoxylin and
Eosin Staining (H&E) [23]. The images were obtained with
a Leica DM1000 optical microscope and the pulmonary
injury was scored by a blinded observer according to the
following criteria [24]: alveolar congestion, hemorrhage,
infiltration or aggregation of neutrophils in the airspace or
vessel wall, and thickness of the alveolar wall. Each item
was graded according to a 5-point scale: 0, minimal (little)
damage; 1, mild damage; 2, moderate damage; 3, severe
damage; and 4, maximum damage. Thus, minimum and
maximum possible scores were 0 and 16, respectively.
Immunohistochemistry
The expression of TGFβ1 was determined by immuno-
histochemical (IHC) staining with a commercial Strept
Actividin-Biotin Complex (SABC) kit (Zhongshan Bio-
logical Technology, Beijing, China). IHC was carried out
using a specific polyclonal anti- TGFβ1 antibody (1:150,
Santa Cruz Biotech, Santa Cruz, CA, USA). The images
were obtained with a Leica DM1000 optical microscope
and analyzed by the image analysis system, Image-Pro
Plus5.1.0.20 (Media Cybernetics, Silver Spring, MD, USA).
Five unduplicated fields were selected in one slide.
RNA extraction and semi-quantitative RT-PCR
Total RNA was extracted from pulmonary tissues with
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according
to the manual. The concentration and purity of total RNA
were determined by a spectrophotometer (Eppendorf,
Hamburg, Germany). Reverse transcription was performedOI
T0 T1 T2
.43 422 ± 25 417 ± 27 420 ± 23
3 ab 420 ± 26 272 ± 25 ab 220 ± 22 ab
3 ac 425 ± 27 318 ± 26 abc 306 ± 26 abc
RI and OI were analyzed. Data are expressed as means ± S.D (n = 6).
ompared with CPB group, c P < 0.05.
Table 3 Effect of NAC on the MDA and SOD levels at different time points
Group MDA (nmol/mg) SOD (U/mg)
T0 T1 T2 T0 T1 T2
Control 10.5 ± 1.0 10.8 ± 1.1 10.9 ± 1.2 154.7 ± 3. 9 150. 8 ± 4.8 151.69 ± 2.7
CPB 12.3 ± 1.5 25.8 ± 1.9 aabb 24.9 ± 1.8 aabb 153.6 ± 4.9 76.9 ± 3.8aa 82.2 ± 3.1aa
NAC 11.6 ± 1.0 16.5 ± 2.4 abbcc 16.2 ± 2.1 abbcc 150.7 ± 2.2 97.3 ± 2.4aabbcc 98.5 ± 3.6aabbcc
Data are expressed as means ± S.D (n = 6). Compared with T0 time point,
a P < 0.05, aa P < 0.01; compared with control group, b P < 0.05, bb P < 0.01; compared with
CPB group, c P < 0.05, cc P < 0.01.
Figure 2 Expression of TGFβ1 mRNA levels at each time point.
After the dogs were killed at each time points, total RNA of lung
was isolated. Semi RT-PCR was performed to detect the TGFβ1
mRNA expression. A. Agarose gel electrophoresis of TGFβ1 and β-
actin; B. Quantities for densitometric analysis of TGFβ1 mRNA. Data
are expressed as mean ± S.D. (n = 6). ** P < 0.01, compared with
control; ## P < 0.01, compared with CPB.
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(Promega, Madison, WI, USA) reverse transcriptase 200
U/20 μl, total RNA 1 μg/20 μl. cDNA was stored at −20°C.
Primers used in the PCR reaction were as follows:
β-actin, forward: 5′- GTA AAG ACC TCT ATG
CCA ACA -3′, reverse: 5′- CTG GAA GGT GGA CAG
TGA G -3′; TGFβ1: forward: 5′ –TAA TGG TGG ACC
GCA ACA AC -3′, reverse: 5′- GTG AGC ACT GAA
GCG AAA GC -3′. PCR reaction was performed with 2 μl
of cDNA, 1 u Taq DNA Polymerase (Fermentas, MBI,
USA) and 0.5 μmol/L of forward and reverse primers,
for a total volume of 20 μl. Reactions were started with
a polymerase activation step at 94°C for 1 min followed
by 30 cycles of 94°C for 1 min, 54 C for 1 min and 72°C
for 1 min, and elongation at 72°C for 10 min. The PCR
products were electrophoresed on a 1.5% agarose gel in
the presence of ethidium bromide, and absorbance was
measured by an image analysis system. The ratio of targets
to β-actin was used to evaluate the significance of the
difference between the two groups.
Statistical analysis
Statistical significance was determined using SPSS 13.0 for
Windows. Measurement data are expressed as means ± S.
D. Student’s t-test was performed to detect any differences
between the two groups. Count data are expressed as
median (range) and the difference in lung injury score
between the two groups was tested using Kruskal-
Wallis rank sum test. Differences were deemed significant
if P < 0.05.
Results
NAC attenuated CPB-induced lung injury
To investigate the effect of NAC on CPB-induced lung
injury, H&E staining was performed. As shown in Figure 1,
fine structure of lung was observed in the control
group, without inflammatory cells infiltration. Smooth
and complete pulmonary alveolar wall without bleeding
and exudate in the pulmonary alveolar and interstitial was
also observed in the lung tissues of control group
(Figure 1). In the CPB group, disorder of the structure of
lung tissues, and a large amount of fluid and a number of
red blood cells in the pulmonary alveolar wall were
observed. Marked hyperemia in the pulmonary alveolarwall, thickening of alveolar septa, edema in the pulmonary
interstitium, extensive infiltration of inflammatory cells and
focal atelectasis were also observed. With the treatment of
NAC, the destruction on the lung structure was obviously
reduced and little inflammatory cells were observed. The
pulmonary injury score of NAC group was much lower
than that of CPB group (Table 1).
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There were no significant changes of RI and OI in control
group post operation (Table 2). Compared with the values
at T0 time point, RI values of CPB and NAC groups were
increased, while OI values were decreased (P < 0.05) at T1
and T2 time points. The RI values of NAC group were
lower and the OI values of NAC group were higher at T1
and T2 time points than those of CPB group, respectively.
NAC regulated MDA and SOD post operation
The MDA levels and the SOD activity are considered
as indicators of lipid peroxidation [25]. Therefore, we
examined the MDA content and the SOD activity in the
dogs’ lung tissues at different time points (Table 3).
There were no obvious changes in MDA content and
SOD activity in control group post the operation. The
MDA content of lung tissues in CPB group was increased
significantly after CPB, while treatment with NAC
inhibited the increase of MDA content. In addition, there
was a significant decrease of SOD activity in the CPB
group at T1 and T2 time points compared with that at T0
time point. However, the decrease of SOD activity was
significantly reversed by NAC treatment.
NAC inhibited the TGFβ1 expression in the lung tissues
To investigate the effect of NAC on the expression of
TGFβ1 in lung tissues, we performed RT-PCR andFigure 3 Expression of TGFβ1 in the lung tissues at each time point.
immunohistochemistry (×200).immunohistochemistry. The expression of TGFβ1 mRNA
increased significantly after CPB compared with those
of control (Figure 2). TGFβ1 protein was also
overexpressed in the lung tissues of dogs in CPB group
after CPB as shown by immunohistochemical staining
(Figure 3). Treatment with NAC significantly suppressed
the TGFβ1 expression in the lung tissues at both mRNA
and protein levels.Discussions
In the present study, we investigated the effect of NAC
on CPB-induced acute lung injury. NAC reduced the
pathological injury of the lung tissues in dogs. NAC
treatment reversed CPB-induced upregulation of RI and
MDA content, and downregulation of OI and SOD
activity. CPB-induced expression of TGFβ1 in the lung
of dogs was also inhibited by NAC treatment. The
results showed that treatment with NAC attenuated the
CPB-induced lung injury, indicating that NAC may be a
potential drug for CPB-induced lung injury.
MDA is the end-products of lipid peroxidation and
is considered as an indicator of the extent of lipid
peroxidation, as well as the degree of tissue injury induced
by oxygen free radicals. SOD is an oxygen free radical
scavenger, reflecting the ability of scavenging oxygen
free radicals. NAC, a micromolecule containing active
hydrosulfide (−SH) with molecular weight of 163.29 g mol-1,Expression of TGFβ1 in lung tissues was determined by
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donor,it can scavenge oxygen free radicals and play a role
in antioxidation directly. In addition, it could be converted
to cysteine by stripping acetyl. Cysteine is the precursor of
reduced glutathione hormone (GSH) which is able to
scavenge oxygen free radicals [26]. Thus, NAC can also
exert antioxidant effect indirectly. In the present study,
our results showed that the MDA level was upregulated,
while the SOD activity was downregulated in the lung
tissues of dogs after CPB. In consistent with previous
study [20], treatment with NAC significantly improved
the lipid peroxidation injury in the lung tissues after CPB,
indicating NAC may play a protective role in CPB-
induced acute lung injury through its antioxidant effect.
TGFβ1 has been shown to be a critical mediator of
acute lung injury [14]. The upregulation of TGFβ1 is
usually related with the increase of the permeability of
pulmonary endothelial monolayers and the permeability
of alveolar epithelial monolayers [8]. The upregulation of
TGFβ1 also leads to the decrease of sodium channel
ENaC on the apical surface of alveolar epithelial cells
[15], subsequently impairing the removal of salt and
water from the alveolar lumen. Interestingly, it has also
been reported that oxygen free radicals could activate
pro-inflammatory nuclear factors, such as NF-κB and
AP-1, and subsequently induce the expression of TGFβ1
[27-30]. Therefore, increased oxygen free radicals level
in the injured lung tissues after CPB potentially lead to
the upregulation of TGFβ1. Furthurmore, TGFβ1 could
promote the release of oxygen free radicals to form the
infernal circle of oxygen free radical-TGFβ1-lung injury.
In the present study, we found NAC could not only
inhibit the lipid peroxidation injury, but also inhibit the
upregulation of TGFβ1 in the lung tissues of dogs after
CPB, indicating that scavenging oxygen free radicals,
attenuating lipid peroxidation, downregulating TGFβ1
expression in the lung tissues and thereby blocking the
infernal circle of oxygen free radical-TGFβ1-lung injury
may be the mechanisms involved in the protective effect
of NAC on CPB-induced acute lung injury in dogs.
Conclusion
In conclusion, our results showed that NAC could alleviate
the acute lung injury induced by CPB in dogs. The
underlying mechanisms include scavenging oxygen free
radicals and downregulating TGFβ1 expression in the
lung tissues after CPB. Our results suggest that NAC is a
potent agent against CPB-induced acute lung injury.
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